MRK.USD · Merck & Co., Inc.
145.70
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$360.56B
PE
14.50
EV/EBITDA
10.2
DIV Yield
3.1%
Payout Ratio
N/A
MQV Rating
5Very Weak
As at 17/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
Low 110.73 - 155.54
Trade Value (12mth)
US$5,020.00
1 week
-4.38%
1 month
20.91%
YTD
25.17%
1 year
0%
All time high
155.54
Additional Data
Shares Outstanding (Fully Diluted)
2,470m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
15-Sep-26
Next Dividend Pay Date
07-Oct-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| OrbiMed Advisors Private Equity | Subsidiary |
| Employees Provident Fund | Pension Fund |
| Robert M. Davis | Individual |
| Sanat Chattopadhyay | Individual |
| Richard R. DeLuca | Individual |
